Tandem Diabetes Care 

$18.50
80
+$0.84+4.76%Friday 08:34

Statistics

Day High
18.5
Day Low
17.66
52W High
21.24
52W Low
12.82
Volume
5,514
Avg. Volume
-
Mkt Cap
1.29B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 5Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.44
-0.3
-0.15
-0.01
Expected EPS
-0.24533
Actual EPS
N/A

Financials

-20.17%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.01BRevenue
-204.71MNet Income

Analyst Ratings

$21.94Average Price Target
The highest estimate is ⁦28.00⁩.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy
40%
Hold
60%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TNDM.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Dexcom
DXCM
Mkt Cap30.69B
Dexcom produces continuous glucose monitoring systems, directly competing in the diabetes management space with Tandem's insulin pumps.
Insulet
PODD
Mkt Cap10.38B
Insulet Corporation offers the Omnipod, an insulin management system that competes with Tandem's insulin pump products.
Medtronic
MDT
Mkt Cap123.49B
Medtronic is a major player in the diabetes care market, offering insulin pumps and continuous glucose monitoring systems that compete with Tandem's offerings.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories produces the FreeStyle Libre, a continuous glucose monitoring system, competing in the broader diabetes management market.
Senseonics
SENS
Mkt Cap502.83M
Senseonics Holdings offers the Eversense CGM system, a direct competitor in the continuous glucose monitoring market.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific, through its life sciences solutions, indirectly competes in the diabetes care market by providing technologies and supplies that support diabetes research and diagnostics.
Novo Nordisk
NVO
Mkt Cap176.43B
Novo Nordisk is a leading global healthcare company that, while primarily known for its diabetes medications, also invests in diabetes care devices and solutions, positioning it as a broader competitor.
Sanofi
SNY
Mkt Cap106.24B
Sanofi is involved in diabetes care through its insulin and glucose monitoring solutions, making it a competitor in the diabetes management space.
Baxter International
BAX
Mkt Cap11.9B
Baxter International offers medical devices that, while not directly competing in the insulin pump or CGM markets, provide various healthcare solutions that can be used in diabetes care.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its medical devices and pharmaceutical segments, has interests in the diabetes market, making it a broader competitor in the healthcare space for diabetes management.

About

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.
Show More
CEO
ISIN
US8753722037

Listings

0 Comments

Share your thoughts

FAQs

What is Tandem Diabetes Care stock price today?▼
The current price of TNDM.BOATS is $18.50 USD — it has increased by +4.76% in the past 24 hours. Watch Tandem Diabetes Care stock price performance more closely on the chart.
What is Tandem Diabetes Care stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Tandem Diabetes Care stocks are traded under the ticker TNDM.BOATS.
What is Tandem Diabetes Care market cap?▼
Today Tandem Diabetes Care has the market capitalization of 1.29B
When is the next Tandem Diabetes Care earnings date?▼
Tandem Diabetes Care is going to release the next earnings report on February 24, 2027.
What is Tandem Diabetes Care revenue for the last year?▼
Tandem Diabetes Care revenue for the last year amounts to 1.01B USD.
What is Tandem Diabetes Care net income for the last year?▼
TNDM.BOATS net income for the last year is -204.71M USD.
In which sector is Tandem Diabetes Care located?▼
Tandem Diabetes Care operates in the Other sector.
When did Tandem Diabetes Care complete a stock split?▼
The last stock split for Tandem Diabetes Care was on October 10, 2017 with a ratio of 1:10.